Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-014044
Filing Date
2022-11-21
Accepted
2022-11-21 16:17:42
Documents
1
Period of Report
2022-11-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57525.html 4  
1 PRIMARY DOCUMENT marketforms-57525.xml 4 3574
  Complete submission text file 0001214659-22-014044.txt   5026
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Issuer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1678 S. PIONEER ROAD SALT LAKE CITY UT 84104
Business Address
Yankton Kevin Bruce (Reporting) CIK: 0001697197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38720 | Film No.: 221405972